Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.

MLA

Vigevani, Luisa, et al. “Molecular Basis of Differential 3’ Splice Site Sensitivity to Anti-Tumor Drugs Targeting U2 SnRNP.” Nature Communications, vol. 8, no. 1, Dec. 2017, p. 2100. EBSCOhost, https://doi.org/10.1038/s41467-017-02007-z.

APA

Vigevani, L., Gohr, A., Webb, T., Irimia, M., & Valcárcel, J. (2017). Molecular basis of differential 3’ splice site sensitivity to anti-tumor drugs targeting U2 snRNP. Nature Communications, 8(1), 2100. https://doi.org/10.1038/s41467-017-02007-z

Chicago

Vigevani, Luisa, André Gohr, Thomas Webb, Manuel Irimia, and Juan Valcárcel. 2017. “Molecular Basis of Differential 3’ Splice Site Sensitivity to Anti-Tumor Drugs Targeting U2 SnRNP.” Nature Communications 8 (1): 2100. doi:10.1038/s41467-017-02007-z.